Dev
Curation
The Premier Voice of the Entire Tech Ecosystem
Read Where the Money Moved
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
Dev
Curation
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
Dev
Curation
Latest
QuantumLight Closes $500M Fund II for Systematic VC
|
Francisco Partners Agrees to Acquire Weave for About $650M
|
Vessev Raises $19M as Electric Hydrofoils Enter the U.S.
|
Math Magic Raises Nearly $50M Across Two AI 3D Rounds
|
Machine Investment Group Closes $350M Real Estate Fund II
|
Crestline Closes $625M European Capital Solutions Fund II
|
Blueprint Finance Raises Strategic Capital for Concrete
|
Muon Space Raises $250M to Industrialize Satellite Scale
|
How VCs Really Evaluate AI Startups with Ray Wu
|
SemiAnalysis Presents: New York Afterhours Unwind
|
QuantumLight Closes $500M Fund II for Systematic VC
|
Francisco Partners Agrees to Acquire Weave for About $650M
|
Vessev Raises $19M as Electric Hydrofoils Enter the U.S.
|
Math Magic Raises Nearly $50M Across Two AI 3D Rounds
|
Machine Investment Group Closes $350M Real Estate Fund II
|
Crestline Closes $625M European Capital Solutions Fund II
|
Blueprint Finance Raises Strategic Capital for Concrete
|
Muon Space Raises $250M to Industrialize Satellite Scale
|
How VCs Really Evaluate AI Startups with Ray Wu
|
SemiAnalysis Presents: New York Afterhours Unwind
Back to Ecosystem Intelligence
ARTAN Bio
Visit Website
Developing engineered suppressor tRNA therapies for diseases caused by nonsense mutations.
Unknown
Early Stage
Total Funding
—
Employees
—
Headquarters
St. Petersburg, Florida
Founded
2023
About
Categories
Funding History
Round
Amount
Date
Lead Investors
Seed
$1M
July 1, 2026
Michael Torres, Ph.D.
Seed
$200K
June 6, 2026
Seed
$200K
June 6, 2026
Seed
$200K
June 6, 2026